Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
About one in six males with grade group 1 prostate most cancers have higher-risk illness, displaying outcomes range and biopsy grade might underestimate...
Keytruda and Padcev generated promising topline outcomes for these with muscle-invasive bladder most cancers who're ineligible for cisplatin-based chemotherapy.Keytruda (pembrolizumab) plus Padcev (enfortumab...
Brian Sluga is now a testicular most cancers survivor after receiving the prognosis when he was 20 years outdated. Compensate for Brian's blogs right...
Hideko Warner, a nurse identified with metastatic breast most cancers, shared her preliminary response to a brand new therapy choice of biology-guided radiation...
